Article

Diabetes in Parliament: 10th – 17th June

House of Commons

House of Commons Questions

Diabetes: Research – DH – Mr Jamie Reed

Mon, 13 June 2016 | House of Commons – Written Answer

Asked by Mr Jamie Reed (Copeland) To ask the Secretary of State for Health, how much Government funding has been allocated to the research of Type 1 Diabetes in each of the last 10 years.

Answered by:
George Freeman
Answered on: 13 June 2016

The information requested is not available.

The Department’s National Institute for Health Research (NIHR) was established in 2006 to increase the volume of applied health research for the benefit of patients and the public, drive faster translation of basic science discoveries into tangible benefits for patients and the economy, and develop and support the people who conduct and contribute to applied health research. The NIHR spent £30.8 million on research relating to metabolic and endocrine disease in 2014/15 (the latest available figure). Most of this investment (£24.4 million in 2014/15) is in infrastructure for research in metabolic and endocrine disease where spend on specific disease areas such as type 1 diabetes cannot be separated from total infrastructure expenditure. This infrastructure including NIHR biomedical research centres and the NIHR Clinical Research Network.

The NIHR funds a wide range of research relating to type 1 diabetes and in 2014/15 the NIHR CRN supported 49 studies in this disease area.

The NIHR Efficacy and Mechanism Evaluation programme is currently seeking to commission research on immunotherapy for type 1 diabetes.


Diabetes – DH – Andrew Bridgen

Mon, 13 June 2016 | House of Commons – Written Answer

Asked by Andrew Bridgen (North West Leicestershire) To ask the Secretary of State for Health, how guidance on finding pathways of continuous glucose monitoring for people with diabetes is communicated to clinical commissioning groups and people applying for such funding.

Asked by Andrew Bridgen (North West Leicestershire) To ask the Secretary of State for Health, what guidance has been issued for the funding pathways of continuous glucose monitoring for people with diabetes.

Answered by:
Jane Ellison
Answered on: 13 June 2016

Clinical commissioning groups (CCGs) are primarily responsible for commissioning diabetes services to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population and are based on the available evidence and take into account national guidelines. This should include consideration of access to continuous glucose monitoring for people with Type 1 diabetes who might benefit from it.


Soft Drinks: Taxation – HM Treasury – Chris Davies

Mon, 13 June 2016 | House of Commons – Written Answer

Asked by Chris Davies (Brecon and Radnorshire) To ask Mr Chancellor of the Exchequer, how his Department determined the bands for the soft drinks industry levy; and what scientific studies were used in reaching that decision.

Answered by:
Damian Hinds
Answered on: 13 June 2016

The new levy will be charged on producers and importers of drinks with added sugar. There will be one rate for drinks with total sugar content above 5g/100ml and a higher charge for drinks with more than 8g/100ml of sugar.

This structure is clear, simple and transparent. It is designed to encourage producers to reformulate their product mix by removing the added sugar content from drinks and helping consumers choose lower and no sugar brands.

The bands have been set to give producers certainty over the next two years before implementation so they can gradually reformulate their products. Companies have until April 2018 before the levy comes into force to reformulate and if they do, they can pay less.


Obesity – DH – Jim Shannon

Wed, 15 June 2016 | House of Commons – Written Answer

Asked by Jim Shannon (Strangford) To ask the Secretary of State for Health, what recent discussions he has had with the Royal College of Nursing on the effect of boredom on obesity.

Answered by:
Jane Ellison
Answered on: 15 June 2016

My Rt. hon. Friend the Secretary of State for Health has not had any such discussions.


House of Lords

Dairy Products – DH – Lord Blencathra

Wed, 15 June 2016 | House of Lords – Written Answer

Asked by Lord Blencathra Asked on: 10 June 2016 Department of Health Dairy Products Lords HL592 To ask Her Majesty’s Government, in the light of the opinion paper by the National Obesity Forum and the Public Health Collaboration Eat Fat, Cut the Carbs and Avoid Snacking to Reverse Obesity and Type 2 Diabetes, whether they plan to revise NHS and Public Health England campaigns that discourage the consumption of dairy products, including full-fat milk, butter, cream and cheese.

Lord Prior of Brampton Answered on: 15 June 2016

Public Health England does not plan to revise its campaigns and dietary advice in light of the recent opinion paper published by the National Obesity Forum and the Public Health Collaboration.

Government advice continues to encourage consumption of dairy products as part of a healthy, balanced diet in line with the Eatwell Guide; advising people to choose lower fat varieties of milk and dairy products where possible, due to the evidence that high intakes of saturated fat are associated with raised blood cholesterol and cardiovascular risk.

Advertisements

Discussion

Comments disabled.